MX2024008372A - Compuestos organicos deuterados y usos de los mismos - Google Patents

Compuestos organicos deuterados y usos de los mismos

Info

Publication number
MX2024008372A
MX2024008372A MX2024008372A MX2024008372A MX2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A MX 2024008372 A MX2024008372 A MX 2024008372A
Authority
MX
Mexico
Prior art keywords
organic compounds
deuterated organic
compounds
formula
preparation
Prior art date
Application number
MX2024008372A
Other languages
English (en)
Spanish (es)
Inventor
Jordi Serrats
Krishna Vadodaria
Kimberly Vanover
Vikram Sudarsan
David Garvey
Original Assignee
Engrail Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Engrail Therapeutics Inc filed Critical Engrail Therapeutics Inc
Publication of MX2024008372A publication Critical patent/MX2024008372A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2024008372A 2022-01-03 2024-07-02 Compuestos organicos deuterados y usos de los mismos MX2024008372A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202263296134P 2022-01-03 2022-01-03
US202263345007P 2022-05-23 2022-05-23
US202263384992P 2022-11-25 2022-11-25
PCT/US2023/010050 WO2023130117A1 (en) 2022-01-03 2023-01-03 Deuterated organic compounds and uses thereof

Publications (1)

Publication Number Publication Date
MX2024008372A true MX2024008372A (es) 2024-12-06

Family

ID=87000368

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024008372A MX2024008372A (es) 2022-01-03 2024-07-02 Compuestos organicos deuterados y usos de los mismos

Country Status (10)

Country Link
US (1) US20250091990A1 (https=)
EP (1) EP4460490A4 (https=)
JP (1) JP2025501410A (https=)
KR (1) KR20240132476A (https=)
AU (1) AU2023204432A1 (https=)
CA (1) CA3242751A1 (https=)
IL (1) IL314019A (https=)
MX (1) MX2024008372A (https=)
TW (1) TW202340145A (https=)
WO (1) WO2023130117A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202333671A (zh) 2022-01-03 2023-09-01 美商恩格瑞爾療法公司 氘化有機化合物及其用途
TW202517609A (zh) 2023-07-02 2025-05-01 美商英格瑞治療公司 氘化有機化合物及其用途(二)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102373288B1 (ko) * 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CN104744333A (zh) * 2013-12-26 2015-07-01 张云 一种奈莫必利的生产方法

Also Published As

Publication number Publication date
WO2023130117A1 (en) 2023-07-06
TW202340145A (zh) 2023-10-16
US20250091990A1 (en) 2025-03-20
EP4460490A1 (en) 2024-11-13
JP2025501410A (ja) 2025-01-17
AU2023204432A1 (en) 2024-07-18
EP4460490A4 (en) 2026-03-18
CA3242751A1 (en) 2023-07-06
IL314019A (en) 2024-08-01
KR20240132476A (ko) 2024-09-03

Similar Documents

Publication Publication Date Title
NI202000078A (es) Compuestos heteroaril tetracíclicos
DOP2025000288A (es) Tetrahidrofuranos sustituidos como moduladores de canales de sodio
UY38602A (es) Compuestos tricíclicos condensados
MX2024008372A (es) Compuestos organicos deuterados y usos de los mismos
ECSP078052A (es) Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas
ECSP078051A (es) Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas
CL2014003181A1 (es) Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas.
UY32462A (es) Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
CO2022004723A2 (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
UY28695A1 (es) Derivados de difenilazetidona
UY28691A1 (es) Derivados de difenilazetidona
UY27882A1 (es) Compuestos quimicos
SV2018005750A (es) Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue
CL2008002768A1 (es) Compuestos derivados de carboxiciclopropil-(bis-fenil-oxamidas); composicion farmaceutica que los contiene; procedimiento para la elaboracion de las composiciones y el uso de los compuestos en el tratamiento de diabetes y trastornos del sncentre otras enfermedades.
AR125457A2 (es) Compuestos inhibidores dobles de magl y faah y composición farmacéutica
MX392270B (es) Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
ECSP088099A (es) Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas
UY37378A (es) Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus
UY40235A (es) Compuestos de heteroarilo para el tratamiento del dolor
MX2021003945A (es) Compuestos de indolinona para uso como inhibidores de map4k1.
MX394108B (es) Derivados de indol n-sustituidos.
AR054786A1 (es) (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1
MX2024008371A (es) Compuestos organicos deuterados y usos de los mismos
EA202091400A1 (ru) Производные пиррола в качестве ингибиторов асс
CL2019001991A1 (es) Moduladores del receptor de estrógeno.